+
Site Tour

bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian

bRIGHT results support the exceptional safety and effectiveness of TriClip TEER in real-world population at 2 years

Download

LEARN MORE:

EuroPCR Symposium 2025 TriClip

Related Resources

Prognosis of TR after MitraClip for MR

Poster: Primary MR in the Very Elderly

TRILUMINATE Pivotal - 2-year update EuroPCR 25

PCR LV 2021: Navitor™ Looking ahead

Navitor Valve in small aortic annuli

ESOC presentation: PFO closure in patients > 60 Years

PCR LV 2021: Navitor™ Live-in-a-box

2-year outcomes from the TRILUMINATE Pivotal trial

PCR LV 2021: Navitor™ 30-day outcomes

TRENDING TOPICS

Prognosis of TR after MitraClip for MR

EXPANDed studies analysis, presented by R. Estevez-Loureiro

Poster: Primary MR in the Very Elderly

Mitral TEER for Primary MR in the very elderly, presented by M. J. Price

TRILUMINATE Pivotal - 2-year update EuroPCR 25

TRILUMINATE Pivotal - 2-year update EuroPCR 2025, presented by G. Singh

CONNEXT


TV
RELATED RESOURCES

Transcatheter Mitral Valve implant

T-TEER: patient selection and current evidence

AV VALVES 2023: TR – Atrial TR

Tendyne™: Animation

CONNEXT


LIVE
RELATED EVENTS

Case Transmission | Tricuspid focus

Review the Trends | Mitral focus

AV Valves Summit 2024 | Closing of Day 1

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline